Cathay Biotech Inc.’s Net Profit Dropped 3.3% in 2022

Cathay Biotech Inc. (上海凯赛生物技术股份有限公司) (688065.SH) reported a net profit of 612.7 million yuan in 2022, down 3.3% year-on-year.

Meanwhile, the company posted 2.4 billion yuan in revenue, up 3.3% year-on-year.

At the end of the reporting period, it had 17.8 billion yuan in total assets and 2.8 billion yuan in total liabilities, with a liability-to-asset ratio of 15.6%.

This article was automatically produced by Caixin Automation on April 27, 2023.

Download our app to receive breaking news alerts and read the news on the go.